Corning Clinical Labs Stands Alone
Corning announced six months ago that it would seek a buyer for its $1.6 billion laboratory testing business, Corning Clinical Laboratories. After talks with competitors, including the two other major national laboratories, SmithKline Beecham Clinical Laboratories and Laboratory Corp. of America Holdings, reportedly broke down, Corning decided to unload the business on shareholders.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.